These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1804462)

  • 1. A stochastic two-stage carcinogenesis model: a new approach to computing the probability of observing tumor in animal bioassays.
    Yang GL; Chen CW
    Math Biosci; 1991 May; 104(2):247-58. PubMed ID: 1804462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically induced preneoplastic lesions in rodents as indicators of carcinogenic activity.
    Williams GM
    IARC Sci Publ; 1999; (146):185-202. PubMed ID: 10353388
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation of rat liver cells in preneoplastic nodules after stimulation of liver growth by xenobiotic inducers.
    Ohde G; Schuppler J; Schulte-Hermann R; Keiger H
    Arch Toxicol Suppl; 1979; (2):451-5. PubMed ID: 88929
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitative analysis of two-dimensional observations of premalignant clones in the presence or absence of malignant tumors.
    De Gunst MC; Luebeck EG
    Math Biosci; 1994 Jan; 119(1):5-34. PubMed ID: 8111136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying effects of various chemicals on preneoplastic and neoplastic lesion development in a wide-spectrum organ carcinogenesis model using F344 rats.
    Fukushima S; Hagiwara A; Hirose M; Yamaguchi S; Tiwawech D; Ito N
    Jpn J Cancer Res; 1991 Jun; 82(6):642-9. PubMed ID: 1906850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.
    Spinardi AL; Kaneno R; Rodrigues MA; Salvadori DM; Rocha NS; Barbisan LF; Ribeiro LR; de Camargo JL
    Jpn J Cancer Res; 1999 Jan; 90(1):101-7. PubMed ID: 10076572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity of methylurea or morpholine in combination with sodium nitrite in rat multi-organ carcinogenesis bioassay.
    Kitano M; Takada N; Chen T; Ito H; Nomura T; Tsuda H; Wild CP; Fukushima S
    Jpn J Cancer Res; 1997 Sep; 88(9):797-806. PubMed ID: 9369926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell differentiation and tumor-promoting action in skin carcinogenesis.
    Raick AN
    Cancer Res; 1974 Nov; 34(11):2915-25. PubMed ID: 4472445
    [No Abstract]   [Full Text] [Related]  

  • 10. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
    Goerttler K; Löhrke H; Hesse B
    Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precancer in mice: animal models used to understand, prevent, and treat human precancers.
    Cardiff RD; Anver MR; Boivin GP; Bosenberg MW; Maronpot RR; Molinolo AA; Nikitin AY; Rehg JE; Thomas GV; Russell RG; Ward JM
    Toxicol Pathol; 2006; 34(6):699-707. PubMed ID: 17074738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic interactions of an arsenic-containing mixture in a multiple organ carcinogenicity bioassay.
    Pott WA; Benjamin SA; Yang RS
    Cancer Lett; 1998 Nov; 133(2):185-90. PubMed ID: 10072168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
    Cohen SM
    Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised rat multi-organ carcinogenesis bioassay for whole-body detection of chemopreventive agents: modifying potential of S-methylcysteine.
    Doi K; Wanibuchi H; Salim EI; Shen J; Wei M; Mitsuhashi M; Kudoh S; Hirata K; Fukushima S
    Cancer Lett; 2004 Mar; 206(1):15-26. PubMed ID: 15019155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ageing and the mechanisms of carcinogenesis: some practical implications.
    Anisimov VN
    J Exp Clin Cancer Res; 1998 Sep; 17(3):263-8. PubMed ID: 9894760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens.
    Dietrich DR; Swenberg JA
    Mutat Res; 1991 Jun; 248(2):239-60. PubMed ID: 2046683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models.
    Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M
    Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of growth of normal and preneoplastic cell populations for tumor promotion in rat liver.
    Schulte-Hermann R; Schuppler J; Timmermann-Trosiener I; Ohde G; Bursch W; Berger H
    Environ Health Perspect; 1983 Apr; 50():185-94. PubMed ID: 6873013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

  • 20. Report of National Cancer Institute symposium: comparison of mechanisms of carcinogenesis by radiation and chemical agents. II. Cellular and animal models.
    Fry RJ
    Basic Life Sci; 1985; 33():43-63. PubMed ID: 4015595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.